Literature DB >> 14631934

ACOG practice bulletin. Cervical Cytology screening. Number 45, August 2003.

.   

Abstract

Although cervical cancer was the leading cause of cancer death in American women as recently as the 1930s, both the incidence and mortality from cervical cancer have decreased by almost one half since the early 1970s, largely as a result of widespread screening with the Pap test (1-3). However, the annual incidence rate has remained at approximately 8 cases per 100,000 women over the past few years (4). New technology for performing cervical cytology is evolving rapidly, as are recommendations for classifying and interpreting the results. The purpose of this document is to provide a review of the best available evidence on screening for cervical cancer. Specific equipment and techniques for performing cervical cytology and interpretation of the results are discussed elsewhere.

Entities:  

Mesh:

Year:  2003        PMID: 14631934     DOI: 10.1016/s0020-7292(03)00412-0

Source DB:  PubMed          Journal:  Int J Gynaecol Obstet        ISSN: 0020-7292            Impact factor:   3.561


  13 in total

1.  Patient knowledge and beliefs as barriers to extending cervical cancer screening intervals in Federally Qualified Health Centers.

Authors:  Nikki A Hawkins; Vicki B Benard; April Greek; Katherine B Roland; Diane Manninen; Mona Saraiya
Journal:  Prev Med       Date:  2013-09-05       Impact factor: 4.018

2.  Trade-offs in cervical cancer prevention: balancing benefits and risks.

Authors:  Natasha K Stout; Jeremy D Goldhaber-Fiebert; Jesse D Ortendahl; Sue J Goldie
Journal:  Arch Intern Med       Date:  2008-09-22

Review 3.  Updated guidelines for papanicolaou tests, colposcopy, and human papillomavirus testing in adolescents.

Authors:  Lea E Widdice; Anna-Barbara Moscicki
Journal:  J Adolesc Health       Date:  2008-07-23       Impact factor: 5.012

4.  Obstetrician-gynecologists' beliefs about performing less cervical cancer screening: the pendulum swings.

Authors:  Allison Schneider; Jillian T Henderson; Cynthia C Harper; Amy Hsu; Mona Saraiya; George F Sawaya
Journal:  Am J Obstet Gynecol       Date:  2015-07-14       Impact factor: 8.661

5.  Maternal Factors and Sexual Orientation-Related Disparities in Cervical Cancer Prevention.

Authors:  Brittany M Charlton; Jessica A Kahn; Vishnudas Sarda; Sabra L Katz-Wise; Donna Spiegelman; Stacey A Missmer; S Bryn Austin
Journal:  Womens Health Issues       Date:  2019-01-11

6.  Cervical cancer screening in the US-Mexico border region: a binational analysis.

Authors:  Dyanne G Herrera; Emily L Schiefelbein; Ruben Smith; Rosalba Rojas; Gita G Mirchandani; Jill A McDonald
Journal:  Matern Child Health J       Date:  2012-12

7.  Cost-effectiveness of human papillomavirus vaccination and cervical cancer screening in women older than 30 years in the United States.

Authors:  Jane J Kim; Jesse Ortendahl; Sue J Goldie
Journal:  Ann Intern Med       Date:  2009-10-20       Impact factor: 25.391

8.  Ending cervical cancer screening: attitudes and beliefs from ethnically diverse older women.

Authors:  George F Sawaya; A Yuri Iwaoka-Scott; Sue Kim; Sabrina T Wong; Alison J Huang; A Eugene Washington; Eliseo J Pérez-Stable
Journal:  Am J Obstet Gynecol       Date:  2008-10-30       Impact factor: 8.661

9.  Health and economic implications of HPV vaccination in the United States.

Authors:  Jane J Kim; Sue J Goldie
Journal:  N Engl J Med       Date:  2008-08-21       Impact factor: 91.245

10.  Cost effectiveness analysis of including boys in a human papillomavirus vaccination programme in the United States.

Authors:  Jane J Kim; Sue J Goldie
Journal:  BMJ       Date:  2009-10-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.